Back |
home / stock / gsk / gsk message board
Subject | By | Source | When |
---|---|---|---|
Lucky Jimmy: GSK up +1.42% percent Today $GSK High is at 45.86 and the Low 45.47 with current volume | Lucky Jimmy | investorshangout | 11/11/2014 8:09:42 PM |
jim50: GSK Gapped up +0.08 $GSK Last Price 45.54 Day High 45.62 Day Low 45.49 Change +0.38 Volume 43 | jim50 | investorshangout | 11/11/2014 4:29:30 PM |
Lucky Jimmy: Monday 6-9-2014 Glaxosmithkline Plc (GSK) $GSK opened at 53.85 hitting the high price o | Lucky Jimmy | investorshangout | 06/09/2014 10:18:50 PM |
Stock Tracker: Latest Glaxosmithkline Plc (GSK) Headlines Better Dividend: GlaxoSmithKline vs. AbbVi | Stock_Tracker | investorshangout | 03/14/2014 4:25:59 AM |
chartguy89: GSK Stock Charts Last: -0.14 Monday, March 3, 2014 at 10:26:51 PM $GSK 1 Month C | chartguy89 | investorshangout | 03/04/2014 3:27:02 AM |
News, Short Squeeze, Breakout and More Instantly...
GlaxoSmithKline PLC Company Name:
GSK Stock Symbol:
NYSE Market:
Over 13 million US adults aged 50-59 years have a medical condition that increases their risk of severe RSV outcomes 1 Clinical development program continues to evaluate safety and immunogenicity in adults 18+ with data read-outs expected H2 2024 GSK plc (LSE/NYSE: GSK) today an...
Updated analysis from Memorial Sloan Kettering Cancer Center presented at ASCO 2024 has expanded to 42 patients with clinical complete response New treatment options are needed for patients facing negative impacts to quality-of-life with current standard of care Additional registrational ...
DREAMM-8 phase III trial showed statistically significant and clinically meaningful improvement in primary endpoint of progression-free survival (PFS) Median PFS not yet reached at 21.8 months median follow-up versus 12.7 months in bortezomib combination Second trial to show robust effica...